To a Problem of Not Increasing Dynamic Compliance at Asthma Patients with Ventilating Disorders after Berotec Inhalation [PDF]
arXiv, 2004 The purpose of research was to check up the influence of decrease of nonequality of ventilating (after bronchodilator (berotec) inhalation (BI)) on the magnitude of dynamic compliance of lungs (Cdyn) at asthma patients with ventilating infringements. Methods and materials: 20 patients (with 2 and 3 degrees of ventilating infringements (VC<73%, FEV1<51%,
arxiv
Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. [PDF]
, 2016 BackgroundDespite inhaled medications that decrease exacerbation risk, some COPD patients experience frequent exacerbations. We determined prospective risk factors for exacerbations among subjects in the COPDGene Study taking inhaled medications ...
, +8 more
core +4 more sources
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
International Journal of COPD, 2019 James F Donohue,1 Donald A Mahler,2,3 Sanjay Sethi4 1Pulmonary Medicine, UNC School of Medicine, Chapel Hill, NC, USA; 2Geisel School of Medicine at Dartmouth, Hanover, NH, USA; 3Director of Respiratory Services, Valley Regional Hospital, Claremont, NH ...
Donohue JF, Mahler DA, Sethi S
doaj
A new role for exhaled nitric oxide as a functional marker of peripheral airway caliber changes: a theoretical study [PDF]
arXiv, 2017 Though considered as an inflammation marker, exhaled nitric oxide (FENO) was shown to be sensitive to airway caliber changes to such an extent that it might be considered as a marker of them. It is thus important to understand how these changes and their localization mechanically affect the total NO flux penetrating the airway lumen (JawNO), hence FENO,
arxiv
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]
, 2012 An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Altman +18 more
core +1 more source
The MABA approach: a new option to improve bronchodilator therapy
European Respiratory Journal, 2013 Recently, the results of an interesting systematic review have shown that the use of a combination of a long-acting β2-agonist (LABA) and a long-acting antimuscarinic agent (LAMA), the so called “dual” bronchodilator therapy, in stable moderate chronic ...
M. Cazzola +2 more
semanticscholar +1 more source
"Safety health impacts of particulate matter from excavation work sites" [PDF]
, 2012 Gli studi epidemiologici hanno evidenziato una relazione lineare tra il particolato aerodisperso e gli effetti sulla salute dell'uomo. E' dunque interessante comprendere quale sia realmente il rischio a cui va incontro la popolazione esposta ad ...
G. Pizzo, M. Clerico
core +1 more source
PLoS ONE, 2013 Objective Adequate symptom control is a problem for many people with asthma. We asked whether weekly email reports on monitored use of inhaled, short-acting bronchodilators might improve scores on composite asthma-control measures.
D. Van Sickle +3 more
semanticscholar +1 more source
International Journal of COPD, 2021 Claus F Vogelmeier,1 Ian P Naya,2,3 François Maltais,4 Leif Bjermer,5 Edward M Kerwin,6 Lee Tombs,7 Paul W Jones,2 Chris Compton,2 David A Lipson,8,9 Isabelle H Boucot2,10 1Department of Medicine, Pulmonary and Critical Care Medicine, University ...
Vogelmeier CF +9 more
doaj
Current GOLD recommendations and its implementation within hospitalised COPD patients in Malta [PDF]
, 2015 In 2012, Global Initiative for Chronic Obstructive Lung Disease (GOLD) revised their classification of Chronic Obstructive Pulmonary Disease patients, incorporating spirometry, symptoms and recent exacerbations.
Bilocca, David +4 more
core